# PolyArginine Treated vEiN grafTs (PATENT)

> **NCT00264706** · PHASE1,PHASE2 · TERMINATED · sponsor: **Lumen Therapeutics** · enrollment: 25 (actual)

## Conditions studied

- Saphenous Vein Graft Disease

## Interventions

- **DRUG:** Nona-L-arginine

## Key facts

- **NCT ID:** NCT00264706
- **Lead sponsor:** Lumen Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-03
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Reformulation of test compound
- **Last updated:** 2016-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264706, "PolyArginine Treated vEiN grafTs (PATENT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00264706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*